95 related articles for article (PubMed ID: 10389594)
1. AML-M0: a review of laboratory features and proposal of new diagnostic criteria.
Stasi R; Amadori S
Blood Cells Mol Dis; 1999 Apr; 25(2):120-9. PubMed ID: 10389594
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical characterization of acute leukemia. Study of 31 bone marrow biopsies].
Rousselet MC; Laniece A; Gardais J; Dautel M; Gardembas-Pain M; Pellier I; Ifrah N; Saint-André JP
Ann Pathol; 1995; 15(2):119-26. PubMed ID: 7538764
[TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
6. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
[TBL] [Abstract][Full Text] [Related]
8. [Various aspects of bone marrow cell proliferation in acute leukemia].
Shmarov DA; Kuchma IuM; Kozinets GI
Ter Arkh; 2001; 73(12):73-7. PubMed ID: 11858117
[TBL] [Abstract][Full Text] [Related]
9. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
11. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
13. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of acute leukemias by use of microarray technology.
Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T
Genes Chromosomes Cancer; 2003 Aug; 37(4):396-405. PubMed ID: 12800151
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
[TBL] [Abstract][Full Text] [Related]
17. [Chromosome 11 rearrangements in the different haematological neoplasias].
Andreeva SV; Drozdova VD; Emel'ianenko LA
Tsitol Genet; 2007; 41(2):42-8. PubMed ID: 17494343
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
[TBL] [Abstract][Full Text] [Related]
19. Modern diagnostics in acute leukemias.
Haferlach T; Kern W; Schnittger S; Schoch C
Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
[TBL] [Abstract][Full Text] [Related]
20. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
